Skip to main content
. 2005 Feb 9;436(2):316–322. doi: 10.1016/j.abb.2005.02.004

Fig. 6.

Fig. 6

Cross-inhibition curves of cell fusion by HR protein preparations. (A) For APMV-2, only the APMV-2 synthetic HR2 peptide had specific virus-cell fusion inhibition activity, and the APMV-2 HR1 peptide had no fusion inhibition activity even if the concentration of the peptide was added to 26 μM; APMV-1 HR1 and HR2 peptides also displayed no fusion inhibition activity. (B) For APMV-1, only the APMV-1 synthetic HR2 peptide had specific virus-cell fusion inhibition activity, and the APMV-1 HR1 peptide had no fusion inhibition activity even if the concentration of the peptide was added to 26 μM; APMV-2 HR1 and HR2 peptides also displayed no fusion inhibition activity.